3, 6-bicyclolides

Details for Australian Patent Application No. 2005314124 (hide)

Owner Enanta Pharmaceuticals, Inc.

Inventors Gai, Yonghua; Tang, Datong; Wang, Zhe; Sun, Ying; Xu, Guoyou; Or, Yat Sun

Agent Pizzeys

Pub. Number AU-B-2005314124

PCT Pub. Number WO2006/063039

Priority 11/008,581 07.12.04 US; none 06.12.05 US

Filing date 6 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 24 April 2008

International Classifications

A61K 31/7048 (2006.01)

C07H 17/08 (2006.01) Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/063039 Priority application(s): WO2006/063039

24 April 2008 Application Accepted

  Published as AU-B-2005314124

15 May 2008 Amendment Made

  The nature of the amendment is: Amend the priority details from Not Given to 11/295,736 06 Dec 2005 US 2005328689 Teva Pharmaceutical Industries Ltd. The nature of the amendment is: Amend the name of the co-inventor FROM: Kotliar, Eleonora Moin TO: Moin Kotliar, Eleonora 2006

21 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005314127-Selecting patients for therapy with a HER inhibitor

2005314122-Automatic power factor corrector